L. Rossier-Pansier

Type de document

Colloques et conférences (1)

Co-auteur

K. Zaman

R. Von Moos

B. Thürlimann

R. Stupp

T. Ruhstaller

C. Ruegg

C. Rochlitz

C. Mamot

N. Gabriel

S. Crowe

S. Aebi

Date

Source

Serveur académique Lausannois (1)

Mot-clé

thérapie (1) test (1) surveillance (1) procès (1) cancer (1) survie (1) Monitoring (1) Treatment (1) Cancer (1) Balances (Weighing instruments) (1) Rectum--Cancer (1) Neovascularization (1) Tumors (1) Therapeutics (1) Swiss (1) Survival (1) Molecules (1) Manufacturers' agents (1) Impact (1) Equilibrium (1) Dates (Fruit) (1) Commission merchants (1) Colon (Anatomy)--Cancer (1) Cancer--Research (1) Cancer--Patients (1) Cancer (1) Breast (1) Doxorubicin (1) Bevacizumab (1) Tumors (1)

Documents écrit par L. Rossier-Pansier (1) | parle de L. Rossier-Pansier (0)

MMP-9 as predictive factor for response and progression free survival in breast cancer patients treated with bevacizumab and pegylated liposomal doxorubicin. A multicenter, single-arm phase II trial (SAKK24/06). On behalf of the Swiss Group for Clinical Cancer Research (SAKK).

K. Zaman et al. (2010)